All In Biotech

Drug Trial Radar · NCT05920356

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers, Negative for PD-L1, and Positive for KRAS p.G12C (CodeBreaK 202)

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 750 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

750

Planned (sponsor's estimate)

Start

Nov 16, 2023

Primary completion

Jun 30, 2027

Study completion Jun 29, 2032

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Jun 27, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objectives are to compare progression-free survival (PFS) and overall survival (OS) in participants who receive sotorasib with platinum doublet chemotherapy versus participants who receive pembrolizumab with platinum doublet chemotherapy.

Conditions

  • Non-Small Cell Lung Cancer (NSCLC)

Interventions

  • SotorasibDrug

    Oral administration

  • PembrolizumabDrug

    Intravenous administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free Survival (PFS)Time frame: Approximately 2.5 years
  2. Overall Survival (OS)Time frame: Approximately 2.5 years

Locations

418 sites in 38 countries. Site status is shown where the registry gives one.

  • Sansum Clinic

    Santa Barbara, California · Recruiting

  • Medical Oncology Hematology Consultants Helen F Graham Cancer Center

    Newark, Delaware · Recruiting

  • Boca Raton Clinical Research Coral Springs

    Coral Springs, Florida · Recruiting

  • Regis Clinical Research LLC

    Miami, Florida · Recruiting

  • Florida Clinical Trials Group Tamarac

    Tamarac, Florida · Recruiting

  • University of Illinois Chicago

    Chicago, Illinois · Recruiting

  • Illinois Cancer Specialists

    Niles, Illinois · Recruiting

  • Medical University of South Carolina

    Waterloo, Iowa · Recruiting

  • Norton Cancer Institute - Brownsboro

    Louisville, Kentucky · Completed

  • Reliant Medical Group Inc

    Worcester, Massachusetts · Recruiting

  • University of New Mexico Cancer Center

    Albuquerque, New Mexico · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Terminated

  • Messino Cancer Centers Asheville

    Asheville, North Carolina · Recruiting

  • Duke University Medical Center Duke Cancer Center

    Durham, North Carolina · Recruiting

  • FirstHealth Cancer Center

    Pinehurst, North Carolina · Recruiting

  • Dayton Physician's Network

    Dayton, Ohio · Recruiting

  • Alliance Cancer Specialists - Media

    Media, Pennsylvania · Recruiting

  • University of Pittsburgh Medical Center Hillman Cancer Center

    Pittsburgh, Pennsylvania · Terminated

  • Guthrie Medical Group

    Sayre, Pennsylvania · Recruiting

  • Medical University of South Carolina Health Lancaster Medical Center

    Lancaster, South Carolina · Recruiting

  • University of Tennessee Medical Center Knoxville

    Knoxville, Tennessee · Terminated

  • Regional One Health

    Memphis, Tennessee · Recruiting

  • Sarah Cannon Research Institute

    Nashville, Tennessee · Recruiting

  • Oncology Consultants PA

    Houston, Texas · Recruiting

  • University of Texas MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • Vista Oncology Inc PS

    Olympia, Washington · Recruiting

  • Mercyhealth

    Janesville, Wisconsin · Recruiting

  • Centro Oncologico Korben

    Capital Federal, Argentina · Recruiting

  • Fundacion Centro Oncológico Riojano Integral para la Investigación y Prevención del Cáncer

    La Rioja, Argentina · Terminated

  • Centro de Diagnostico Investigacion y Tratamiento

    Salta, Argentina · Recruiting

  • Instituto Argentino de Diagnostico y Tratamiento IADT

    CABA, Buenos Aires, Argentina · Terminated

  • Hospital Britanico de Buenos Aires

    CABA, Buenos Aires, Argentina · Terminated

  • Instituto Alexander Fleming

    Capital Federal, Buenos Aires, Argentina · Recruiting

  • Hospital Italiano de La Plata

    La Plata, Buenos Aires, Argentina · Recruiting

  • Fundacion Ars Medica

    San Salvador de Jujuy, Jujuy Province, Argentina · Terminated

  • Clinica Viedma

    Viedma, Río Negro Province, Argentina · Recruiting

  • Fundacion Estudios Clinicos

    Rosario, Santa Fe Province, Argentina · Recruiting

  • Sanatorio Parque SA

    Rosario, Santa Fe Province, Argentina · Recruiting

  • Campbelltown Hospital

    Campbelltown, New South Wales, Australia · Recruiting

  • Concord Repatriation General Hospital

    Concord, New South Wales, Australia · Recruiting

Showing 40 of 418 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.